Shop by Category
Peptide blends
BPC-157/TB-500 10+10mg
Summary Description: BPC-157 and TB-500 is an investigational blend of two well-studied peptides known for their regenerative and cytoprotective properties. BPC-157, derived from a gastric protein, is recognized for promoting angiogenesis, cellular migration, and tissue healing across various organ systems1,2. TB-500, a synthetic fragment of thymosin beta-4, enhances cellular motility, reduces inflammation, and stimulates new blood vessel formation3,4. Together, this synergistic blend is being explored in preclinical research for its ability to accelerate wound healing, mitigate inflammation, and enhance recovery in models of soft tissue injury, nerve damage, and musculoskeletal trauma. While individually effective, the co-administration of BPC-157 and TB-500 may produce more robust regenerative outcomes by targeting both the structural and signaling components of tissue repair.
Products will arrive in a lyophilized (powder) form for maximum stability
BPC-157/TB-500/GHK-Cu 10+10+50mg (GLOW blend 70mg)
Summary Description: The GLOW Peptide Blend is a synthetic combination of three well-characterized regenerative peptides: BPC-157, TB-500, and GHK-Cu, each with complementary mechanisms that promote cellular repair, angiogenesis, and tissue remodeling. The blend integrates the nitric oxide-mediated cytoprotective activity of BPC-157, the actin-regulating and pro-angiogenic functions of TB-500, and the copper-mediated antioxidant and anti-fibrotic properties of GHK-Cu. Collectively, this tri-peptide formulation provides a multifaceted approach to studying regeneration, inflammation resolution, and extracellular matrix restoration in preclinical models
Products will arrive in a lyophilized (powder) form for maximum stability
BPC-157/TB-500/KPV/GHK-Cu 10+10+10+50mg (KLOW blend 80mg)
Summary Description: The KLOW Peptide Blend is a comprehensive anti-aging and regenerative peptide complex that combines BPC-157, TB-500, GHK-Cu, and KPV to restore cellular vitality, improve tissue resilience, and counteract age-related degeneration. This synergistic formulation targets several hallmarks of aging (chronic inflammation, oxidative stress, vascular decline, and collagen loss) to promote youthful structural integrity and enhanced cellular function1-5.
Products will arrive in a lyophilized (powder) form for maximum stability
Cagrilintide/Semaglutide Blend 5+5mg
Summary Description: Cagrilintide and semaglutide are two structurally unrelated peptide-based therapeutic agents (an amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist, respectively). The co-administration of cagrilintide and semaglutide leverages their complementary mechanisms for enhanced weight management and glycemic control, promoting significant reductions in bodyweight and improvements in metabolic health in populations with overweight, obesity, and type 2 diabetes1-3.
Products will arrive in a lyophilized (powder) form for maximum stability
CJC-1295 (No DAC)/Ipamorelin Blend 5+5mg
Summary Description: The CJC-1295 (no DAC) + Ipamorelin peptide blend merges two potent growth hormone secretagogues to synergistically enhance physiologic GH pulsatility. This research-only combination stimulates both GHRH and ghrelin receptor pathways, yielding amplified and sustained GH release while maintaining endocrine feedback sensitivity.